Table 4.

Malondialdehyde (MDA) (mM/mg of protein) concentrations in plasma, heart, aorta, lung, brain and kidney of untreated and Mercury (HgCl₂)-treated Wistar rats and spontaneously hypertensive rats (SHRs)

	Wistar Control n = 6	Wistar HgCl2-treated n = 6	SHR Control n = 6	SHR HgCl2-treated n = 7
Plasma	0.93 ± 0.15	1.28 ± 0.44*	0.89 ± 0.22	0.92 ± 0.05
Heart	0.22 ± 0.03	0.28 ± 0.03*	0.45 ± 0.05	0.55 ± 0.05&
Aorta	0.13 ± 0.03	0.12 ± 0.05	0.96 ± 0.27	1.51 ± 0.37&
Lung	0.18 ± 0.05	0.14 ± 0.03	0.21 ± 0.03	0.12 ± 0.03&
Brain	0.13 ± 0.03	0.09 ± 0.03	0.54 ± 0.07	0.34 ± 0.03&
Kidney	0.38 ± 0.07	0.14 ± 0.03*	0.96 ± 0.07	0.51 ± 0.03&

Values are expressed in mM/mg of protein (MDA). The results represent the mean ± SD. N-Number of animals used. One-way ANOVA, post hoc Tukey's.

^*p < 0.05 vs Wistar Control and

^&p < 0.05 vs SHR Control.